Jacobs Levy Equity Management Inc. Invests $687,000 in Trupanion, Inc. (NASDAQ:TRUP)

Jacobs Levy Equity Management Inc. purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 14,258 shares of the financial services provider’s stock, valued at approximately $687,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock worth $173,362,000 after purchasing an additional 45,653 shares during the period. Marshall Wace LLP boosted its holdings in Trupanion by 6.9% in the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock worth $43,459,000 after purchasing an additional 57,804 shares during the period. Balyasny Asset Management L.P. boosted its holdings in Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after purchasing an additional 661,559 shares during the period. Baillie Gifford & Co. boosted its holdings in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after purchasing an additional 147,341 shares during the period. Finally, Northern Trust Corp lifted its stake in Trupanion by 9.0% in the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider’s stock valued at $17,749,000 after buying an additional 30,549 shares during the last quarter.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $46.77 on Friday. Trupanion, Inc. has a fifty-two week low of $25.90 and a fifty-two week high of $57.90. The firm’s 50-day simple moving average is $37.96 and its 200 day simple moving average is $44.27. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock has a market cap of $2.00 billion, a P/E ratio of -203.35, a P/E/G ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $341.98 million for the quarter, compared to analysts’ expectations of $337.81 million. During the same period in the previous year, the business earned ($0.16) earnings per share. The company’s revenue was up 11.7% on a year-over-year basis. Equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on TRUP shares. Stifel Nicolaus cut their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler cut their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Finally, Lake Street Capital cut their target price on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and an average price target of $51.80.

Insiders Place Their Bets

In other Trupanion news, insider Brenna Mcgibney sold 5,000 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at approximately $123,316.62. The trade was a 57.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the sale, the chief executive officer now owns 118,784 shares in the company, valued at approximately $3,728,629.76. This trade represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,792 shares of company stock worth $1,122,802. 5.42% of the stock is owned by corporate insiders.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.